GVS S.p.A (DE:4YQ)
FRANKFURT:4YQ
4YQ Stock Chart & Stats
€4.10
-€0.09(-1.79%)
At close: 4:00 PM EST
€4.10
-€0.09(-1.79%)
Day’s Range― - ―
52-Week Range€3.19 - €5.57
Previous CloseN/A
Volume0.00
Average Volume (3M)66.00
Market Cap
€796.44M
Enterprise Value€1.04B
Total Cash (Recent Filing)€101.56M
Total Debt (Recent Filing)€348.40M
Price to Earnings (P/E)28.1
Beta0.85
Next Earnings
Sep 08, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.16
Shares Outstanding189,177,690
10 Day Avg. Volume0
30 Day Avg. Volume66
Financial Highlights & Ratios
PEG Ratio-0.82
Price to Book (P/B)1.64
Price to Sales (P/S)1.69
P/FCF Ratio75.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€5.63Price Target Upside37.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.26
Revenue Forecast (FY)€431.71M
Bulls Say, Bears Say
Bulls Say
Diversified End MarketsGVS sells filtration products into healthcare/life-sciences and industrial end markets, reducing concentration risk. This cross-market exposure smooths demand swings, preserves order streams from regulated healthcare customers, and supports more durable revenue over the next several months.
Improved LeverageMaterial reduction in debt-to-equity meaningfully lowers financial risk and increases flexibility. A stronger balance sheet supports capital spending, working-capital management or targeted investments without immediate liquidity strain, enhancing resilience over a 2–6 month horizon.
Recurring Consumable DemandGVS benefits from consumable and replacement sales and validated OEM supplier positions in regulated markets. Recurring demand and higher switching costs from product qualification create predictable revenue streams and customer retention that persist across quarters.
Bears Say
Sharp TTM Revenue DeclineTrailing-twelve-month revenue has fallen sharply after a period of flat-to-down sales. Sustained top-line contraction reduces scale benefits, constrains reinvestment capacity, and pressures medium-term growth prospects unless volume or new customer wins resume.
Compressed MarginsMargins have declined materially from 2024 levels, leaving net margin near ~4%. Persistently thin operating margins limit the firm's ability to absorb cost inflation, invest in R&D or pricing initiatives, and weaken sustainable profitability over coming months.
Weak Free Cash Flow & ConversionFCF has collapsed to low single-digit millions and is a small fraction of net income, indicating poor cash conversion. Limited free cash curtails dividends, buybacks, or capex flexibility and raises vulnerability to working-capital swings or cyclical downturns.
GVS S.p.A News
4YQ FAQ
What was GVS S.p.A’s price range in the past 12 months?
GVS S.p.A lowest stock price was €3.19 and its highest was €5.57 in the past 12 months.
What is GVS S.p.A’s market cap?
GVS S.p.A’s market cap is €796.44M.
When is GVS S.p.A’s upcoming earnings report date?
GVS S.p.A’s upcoming earnings report date is Sep 08, 2026 which is in 89 days.
How were GVS S.p.A’s earnings last quarter?
GVS S.p.A released its earnings results on May 20, 2026. The company reported €0.06 earnings per share for the quarter, the consensus estimate of €0.06 by €0.
Is GVS S.p.A overvalued?
According to Wall Street analysts GVS S.p.A’s price is currently Undervalued.
Does GVS S.p.A pay dividends?
GVS S.p.A does not currently pay dividends.
What is GVS S.p.A’s EPS estimate?
GVS S.p.A’s EPS estimate is 0.08.
How many shares outstanding does GVS S.p.A have?
GVS S.p.A has 189,177,690 shares outstanding.
What happened to GVS S.p.A’s price movement after its last earnings report?
GVS S.p.A reported an EPS of €0.06 in its last earnings report, expectations of €0.06. Following the earnings report the stock price went down -1.174%.
Which hedge fund is a major shareholder of GVS S.p.A?
Currently, no hedge funds are holding shares in DE:4YQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GVS S.p.A
GVS S.p.A., alongside its subsidiaries, is a global manufacturer and distributor of advanced filtration solutions, serving diverse applications across the healthcare and life science, energy and mobility, and health and safety industries. For health and safety, the company develops air purification components for items like hand dryers, vacuum cleaners, and specialized nail station ventilation, in addition to fume extraction and HVAC systems, and a comprehensive range of personal protective equipment including masks and powered air purifying respirators. In the healthcare and life science sectors, GVS provides critical filtration technologies for medical devices such as respiratory and anesthesia equipment, autoclaves, and spirometry units, alongside liquid filtration components for IV lines and blood processing. Their offerings also encompass a broad portfolio of laboratory and diagnostic products, including various membranes, microfiltration devices, DNA/RNA test kits, and environmental monitoring solutions. For energy and mobility, GVS supplies components for automotive systems, such as fuel and engine air intake filters, SCR urea systems, ABS, ESP, and brake systems, as well as solutions for electric vehicle (EV) applications and batteries. Founded in 1979, the company initially operated as GVS S.r.l. before rebranding to GVS S.p.A. in 2001. GVS S.p.A. maintains its headquarters in Zola Predosa, Italy, and functions as a subsidiary of GVS Group S.p.A.
4YQ Stock 12 Month Forecast
Average Price Target
€5.63
▲(37.40% Upside)
Technical Analysis
Comer Industries SpA
―
ILPRA SpA
―
Industrie De Nora SpA
―
LU-VE SpA
―
Marzocchi Pompe S.p.A.
―
Options Prices
Currently, No data available
---